Webinar: Technischer Ausblick auf das 2. HJ mit Jörg Scherer von HSBC. Wie geht es bei DAX®, Öl und Gold weiter?
Am 27.6. um 18:30 Uhr reinschalten!
21.05.2019 20:18

Top Stock Reports for Disney, Coca-Cola & Gilead

Tuesday, May 21, 2019The Zacks Research Daily presents the best research output of our analyst team. Today's Research Daily features new research reports on 16 major stocks, including Disney (DIS), Coca-Cola (KO) and Gilead (GILD). These research reports have been hand-picked from the roughly 70 reports published by our analyst team today.You can see all of today’s research reports here >>>Disney’s shares have gained +28.7% over the past year, outperforming the Zacks Media Conglomerates industry’s gain of +23% during the same period. The Zacks analyst thinks Disney’s second-quarter fiscal 2019 top-line growth was driven by strong performance of DTCI and Parks, Experiences & Consumer Products segments. Higher guest spending and attendance and increase in consumer products business aided Parks segment revenues. Additionally, Disney’s most-awaited movie, Avengers: Endgame, which recorded phenomenal box-office success, is expected to aid fiscal 2019 top line. However, second-quarter fiscal 2019 operating income decreased due to lower theatrical and home entertainment results and higher costs. Increasing investments in ESPN and Disney+ and losses from streaming technology services hurt DTCI segment operating income. Moreover, due to the ongoing investments, Disney anticipates DTCI operating loss to be higher in third-quarter fiscal 2019.(You can read the full research report on Disney here >>>).Shares of Coca-Cola have increased +15.6% in the past year, outperforming the Zacks Soft Drinks Beverages industry which has gained +7.2% over the same period. The Zacks analyst thinks this is largely attributable to the effective execution of strategies to evolve as a consumer-centric total beverage company. This bolstered the company’s quarterly performances as evident from a robust surprise trend. First-quarter 2019 marked its seventh positive earnings surprise in the last eight quarters and seventh straight sales beat. Top and bottom lines benefited from ongoing productivity efforts and disciplined growth strategies along with robust performance across all segments. Further, innovation and investment in core categories and brands have been the key focus area for Coca-Cola, which has led to the expansion of retail value share. Its transformative global re-franchising initiatives are expected to boost margins. However, the company expects adverse currency rates to significantly hurt comparable revenues and operating income in the second quarter and 2019.(You can read the full research report on Coca-Cola here >>>).Buy-ranked Gilead’s shares have outperformed the Zacks Biotech industry year to date, gaining +5.3% vs. an increase of +0.3%. Although the sales miss was disappointing, Gilead’s earnings beat the consensus mark in the first quarter. Soft HCV franchise sales stabilized as compared to the levels in prior quarters.The Zacks analyst thinks Gilead’s HIV franchise maintains momentum on continued uptake of Genvoya and Odefsey, and the rapid adoption of Biktarvy. Meanwhile, it shifted focus to the HIV franchise, and newer avenues like CAR-T therapy and NASH. Gilead’s collaboration with Novo Nordisk for NASH treatments is a step in the right direction, given its recent debacles. The company suffered a setback with the failure of a late-stage study on selonsertib in patients with compensated cirrhosis (F4) due to NASH. It is also developing a pipeline targeting inflammatory diseases. Data from phase III studies on filgotinib were also encouraging. A potential filing is planned by the end of this year.(You can read the full research report on Gilead here >>>).Other noteworthy reports we are featuring today include CME Group (CME), Concho Resources (CXO) and Entergy (ETR).Will you retire a millionaire?One out of every six people retires a multimillionaire. Get smart tips you can do today to become one of them in a new Special Report, “7 Things You Can Do Now to Retire a Multimillionaire.”Click to get it free >>Mark VickerySenior EditorNote: Sheraz Mian heads the Zacks Equity Research department and is a well-regarded expert of aggregate earnings. He is frequently quoted in the print and electronic media and publishes the weekly Earnings Trends and Earnings Preview reports. If you want an email notification each time Sheraz publishes a new article, please click here>>> Today's Must Read Robust Parks & Resorts, Studio Strength Drive Disney (DIS) Investment & Innovation Reflect Coca-Cola's (KO) Core Strength Strong HIV Franchise, CAR-T, Stable HCV Boost Gilead (GILD) Featured Reports Concho (CXO) Rides on RSP Permian Buyout, High Capex a Worry The acquisition of RSP Permian has boosted Concho's scale and production prospects. However, high 2019 capex forecast of $2.9 billion may impact overall cash flows, per the Zacks analyst. Project Investments Aid Entergy (ETR), High Debt Levels Hurt Per the Zacks analyst, Entergy's disciplined investments in growth projects bolsters its prospects. However, massive debt levels can be a major headwind for the company going ahead. Production from U.S. Resource Plays Boost Marathon (MRO) Marathon Oil expects oil production from U.S. resource plays to rise 12% in 2019. However, the Zacks analyst is worried over the lack of clarity on dividend increase. Favorable Budget, Solid Cash Flow Aid Leidos Holdings (LDOS) Per the Zacks analyst, favorable U.S. budgetary amendments are boosting Ledios Holdings' growth. Aqua America (WTR) to Gain from Acquisitions & Investments Per the Zacks analyst, 64 acquisitions in the last five years and $1.4 billion investment in the 2019-2021 time frame to strengthen infrastructure will drive Aqua America's performance. (WIX) User Base Grows Wider, Spending on the Rise According to the Zacks analyst, Wix is benefiting from product innovations and collaborations, favoring premium subscriber growth. AGCO (AGCO) Rides on Strategic Investments, Improving Demand The Zacks analyst expects AGCO to gain from improving global farm equipment demand and focus on strategic investments to expand product lines and improving factory productivity. New Upgrades Ubiquiti (UBNT) Buoyed by Strong Enterprise Technology Unit Per the Zacks analyst, growth in global Enterprise Technology business driven by increasing market traction of UniFi products, including switches & security gateways, should drive Ubiquiti's top line. New Strategic Acquisitions, Organic Growth Aid Bruker (BRKR) The Zacks analyst is optimistic about buyouts of Hain, Mestrelab and Alicona Imaging which have started to contribute to the top line strongly. Series of product launches are driving organic growth. Sturdy Global OAS Sales Lift Cardiovascular Systems (CSII) The Zacks analyst is hopeful about Cardiovascular Systems gaining strong momentum internationally, banking on the commercial launch of orbital atherectomy system (OAS) in several geographies. New Downgrades Increasing Expenses Weigh On CME Group's (CME) Margins Per the Zacks analyst, the company's expenses have been increasing for the past many years due to investment in technology and benefit expenses and are weighing on its margins. Soaring Costs & Lower Vehicle Production Hurt Magna (MGA) Per the Zacks analyst, elevated program launch costs and higher engineering spending to develop technology is impeding Magna's profit. Also, declining light vehicle production in key markets is a woe. HRB Block (HRB) Grapples With Higher Expenses, Litigations The Zacks analyst is worried about H&R Block's rising expenses due to heavy investments in technology and operations. The company also faces litigation related to its various operating activities. undefined undefined Coca-Cola Company (The) (KO): Free Stock Analysis Report Gilead Sciences, Inc. (GILD): Free Stock Analysis Report Entergy Corporation (ETR): Free Stock Analysis Report The Walt Disney Company (DIS): Free Stock Analysis Report Concho Resources Inc. (CXO): Free Stock Analysis Report CME Group Inc. (CME): Free Stock Analysis Report To read this article on click here. Zacks Investment Research
Weiter zum vollständigen Artikel bei "Zacks"
Quelle: Zacks

Nachrichten zu Coca-Cola Co.

  • Relevant
  • Alle
  • vom Unternehmen
  • Peer Group
  • ?

Um Ihnen die Übersicht über die große Anzahl an Nachrichten, die jeden Tag für ein Unternehmen erscheinen, etwas zu erleichtern, haben wir den Nachrichtenfeed in folgende Kategorien aufgeteilt:

Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen

Alle: Alle Nachrichten, die dieses Unternehmen betreffen. Z.B. auch Marktberichte die außerdem auch andere Unternehmen betreffen

vom Unternehmen: Nachrichten und Adhoc-Meldungen, die vom Unternehmen selbst veröffentlicht werden

Peer Group: Nachrichten von Unternehmen, die zur Peer Group gehören

Analysen zu Coca-Cola Co.

  • Alle
  • Buy
  • Hold
  • Sell
  • ?
24.04.2019Coca-Cola NeutralUBS AG
24.04.2019Coca-Cola NeutralJP Morgan Chase & Co.
23.04.2019Coca-Cola NeutralJP Morgan Chase & Co.
18.04.2019Coca-Cola buyDeutsche Bank AG
12.03.2019Coca-Cola HoldHSBC
18.04.2019Coca-Cola buyDeutsche Bank AG
15.02.2019Coca-Cola OutperformRBC Capital Markets
13.02.2019Coca-Cola OutperformRBC Capital Markets
19.11.2018Coca-Cola OutperformRBC Capital Markets
31.10.2018Coca-Cola buyHSBC
24.04.2019Coca-Cola NeutralUBS AG
24.04.2019Coca-Cola NeutralJP Morgan Chase & Co.
23.04.2019Coca-Cola NeutralJP Morgan Chase & Co.
12.03.2019Coca-Cola HoldHSBC
15.02.2019Coca-Cola NeutralUBS AG
16.02.2018Coca-Cola SellGoldman Sachs Group Inc.
10.01.2018Coca-Cola SellGoldman Sachs Group Inc.
17.11.2017Coca-Cola SellGoldman Sachs Group Inc.
16.11.2017Coca-Cola SellGoldman Sachs Group Inc.
26.10.2017Coca-Cola SellGoldman Sachs Group Inc.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Coca-Cola Co. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"

Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"

Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen
Börse Stuttgart Anlegerclub

Die richtige Strategie für die Börsenkrise

Stecken Sie nicht den Sand in den Kopf, sondern kaufen Sie die richtigen Aktien. Erfahren Sie im aktuellen Anlegermagazin mehr über attraktive Qualitätsaktien und zyklische Aktien
Kostenfrei registrieren und lesen!

Heute im Fokus

Wall Street beendet Handel wenig bewegt -- DAX schließt mit kleinem Plus -- Hedgefonds-Investor Elliott steigt bei Bayer ein -- FedEx, thyssenkrupp im Fokus

Deutsche Bank anscheinend vor Einigung über Arbeitsplatzabbau. Bitcoin nahe 13.000-Dollar-Marke. Bayer holt sich im Glyphosat-Streit renommierte US-Berater. TLG IMMOBILIEN will mit Kapitalerhöhung zu frischem Geld kommen. Apple kauft zu. Infineon-Aktie und Siltronic-Papiere legen zu: Chipwerte erholen sich nach optimistischen Signalen von Micron.

Die 5 beliebtesten Top-Rankings

Diese Sternchen haben ihren eigenen Aktien-Index
Diese Aktien hat Warren Buffett im Depot
Die Änderungen unter den Top-Positionen
Die erfolgreichsten Kinofilme der letzten 25 Jahre
Welche Titel knackten die Milliardenmarke an den Kinokassen?
In diesen Berufen bekommt man das niedrigste Gehalt
Welche Branchen man besser meiden sollte.
DIe innovativsten Unternehmen
Diese Unternehmen sind am fortschrittlichsten
mehr Top Rankings


Die USA suchen Verbündete gegen den Iran. Sollte sich Deutschland einer solchen Allianz anschließen?

Online Brokerage über Brokerage
Handeln Sie für nur 5 Euro Orderprovision* pro Trade aus der Informationswelt von!


Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln
Kontakt - Impressum - Werben - Pressemehr anzeigen
Top News
Beliebte Suchen
DAX 30
Euro US-Dollar
Wirecard AG747206
Deutsche Bank AG514000
Daimler AG710000
Infineon AG623100
Microsoft Corp.870747
thyssenkrupp AG750000
Apple Inc.865985
Siemens AG723610
Lufthansa AG823212